• Submit a Referral
  • Rapid Refer
  • Upload Files

FDA APPROVES CYMBALTA MEDICATION FOR USE TO TREAT CHRONIC BACK PAIN – INCREASED COSTS FOR WCMSA ANTICIPATED

Nov 6, 2010

By Alvena Ferreira, RN, CCM, CNLCP, MSCC and Katie A. Fox, MSCC On November 5, 2010 the FDA approved Cymbalta (duloxetine hydrochloride), an antidepressant, to treat chronic back pain as well as osteoarthritis. The dosage that can be prescribed is 60 mg/day. ...

Recent Posts

  • Medicare Updates: CMS NGHP Beneficiary Recovery Webinar & Medicare conditional payment “round-up”
  • CMS releases updated Medicare Secondary Payer Recovery Portal (MSPRP) user guide (Version 5.0) – updated functionality made to the claims listing interface
  • CMS Releases New WCMSA Reference Guide (Version 3.2)
  • CMS releases new NGHP Section 111 User Guide (Version 6.0) and updated accepted/excluded ICD code listings
  • CMS discusses conditional payment appeal issues on its NGHP Applicable Plans webinar

Categories

Archives

Site Terms | Privacy Policy
VERISK ANALYTICS®